Clinical Trial Update: Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avastin (bevacizumab) to reverse acquired estrogen independence in previously hormone-responsive metastatic breast cancer; completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-09-27